Bloomberg -- Merck & Co., the second-largest U.S. drugmaker, reported a 79 percent drop in first-quarter profit on acquisition costs and projected 2010 earnings below what some analysts were expecting.
Bloomberg -- Merck & Co., the second-largest U.S. drugmaker, reported a 79 percent drop in first-quarter profit on acquisition costs and projected 2010 earnings below what some analysts were expecting.
